Laura Kelso
Acute Care · Chicago, ILNPI 1457123226
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,886 of the $2,946 with a category attached, or 64.0%. Medtronic accounts for 64.3% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $2,160 and has fallen 68.0% since, to $691 in 2025. Among acute care clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 33 payments — averaging $89.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Abiomed$824
- Abbott$50
- Pfizer$45
- Alnylam Pharmaceuticals Inc.$44
- AstraZeneca$43
- plus $44 from 2 others
What the payments were for
- Travel & lodging$1,05936%
- Food & beverage$1,88664%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 17 | $1,895 |
| Abiomed | 8 | $824 |
| Abbott | 1 | $50 |
| Pfizer | 2 | $45 |
| Alnylam Pharmaceuticals Inc. | 1 | $44 |
| AstraZeneca | 2 | $43 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $29 |
| Lexicon Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$264
How this compares
$2,946 in reported general payments places this provider in the 90th percentile of 461 acute care providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 20 | $13,517 |
| Piperacillin-TazobactamPiperacillin Sodium/Tazobactam | 13 | $3,519 |
| Bumetanide | 13 | $916 |
| Amiodarone Hcl | 14 | $768 |
| Potassium Chloride | 25 | $598 |
| Warfarin Sodium | 56 | $440 |
| Doxycycline Hyclate | 14 | $333 |
| Cephalexin | 15 | $237 |
| Losartan Potassium | 26 | $218 |
| Hydralazine Hcl | 18 | $157 |
| Gabapentin | 12 | $133 |
| Carvedilol | 15 | $112 |
| Spironolactone | 18 | $86 |
| Furosemide | 14 | $51 |
Paid to pharmacies, not to this prescriber.
Other acute care in Chicago
- Tedra GrayChicago$78K
- Gwen CassidyChicago$46K
- Erin DarguzasChicago$17K
- Sarah MiyataChicago$11K
- Katie MeadorChicago$10K
- Viktoriya KaganChicago$8K
- Laura RitchieChicago$5K
- Christine Joy LocquiaoChicago$5K
- Janice AmslerChicago$5K
- Julie MudgeChicago$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.